Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer

Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer

Introduction: Despite improvements in radiation therapy, chemotherapy and surgical procedures over the last 30 years, pancreatic cancer 5-year survival rate remains at 9%. Reduced stroma permeability and heterogeneous blood supply to the tumour prevent chemoradiation from making a meaningful impact...

Full description

Bibliographic Details
Main Authors: Mikaela Dell’Oro, Michala Short, Puthenparampil Wilson, Eva Bezak
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Cancers
Subjects:
pancreatic cancer
proton therapy
carbon ion therapy
stereotactic body radiation therapy
hypoxia activated prodrug
radiosensitizer
Online Access:https://www.mdpi.com/2072-6694/12/1/163

Similar Items

Similar Items